Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontin

Statistical power analyses using G∗Power 3.1: tests for correlation and regression analyses

Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009) · Behavior Research Methods · doi:10.3758/brm.41.4.1149 · Cited by 37,615

Analyzing real-time PCR data by the comparative CT method

Schmittgen, T. D., & Livak, K. J. (2008) · Nature Protocols · doi:10.1038/nprot.2008.73 · Cited by 26,190

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw377 · Cited by 10,799

DAVID: Database for Annotation, Visualization, and Integrated Discovery

Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345

NAFLD: A multisystem disease

Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,162

The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study

Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890

Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis

Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492

Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287

Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Govaere, O., Cockell, S., Tiniakos, D., Queen, R., Younes, R., Vacca, M., Alexander, L., Ravaioli, F., Palmer, J., Petta, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aba4448 · Cited by 479

Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors

Francque, S., Szabo, G., Abdelmalek, M. F., Byrne, C. D., Cusi, K., Dufour, J.-F., Roden, M., Sacks, F., & Tacke, F. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00366-5 · Cited by 316

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

Suppli, M. P., Rigbolt, K. T. G., Veidal, S. S., Heebøll, S., Eriksen, P. L., Demant, M., Bagger, J. I., Nielsen, J. C., Oró, D., Thrane, S. W., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00358.2018 · Cited by 288

Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome

Rom, O., Liu, Y., Liu, Z., Zhao, Y., Wu, J., Ghrayeb, A., Villacorta, L., Fan, Y., Chang, L., Wang, L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2841 · Cited by 301

The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity

Van Herck, M. A., Weyler, J., Kwanten, W. J., Dirinck, E. L., De Winter, B. Y., Francque, S. M., & Vonghia, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00082 · Cited by 238

Dietary cholesterol promotes steatohepatitis related hepatocellular carcinoma through dysregulated metabolism and calcium signaling

Liang, Q., Teoh, N., Xu, L., Pok, S., Li, X., Chu, E. S., Chiu, J., Dong, L., Arfianti, A., Haigh, W. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06931-6 · Cited by 229

Gene Expression Predicts Histological Severity and Reveals Distinct Molecular Profiles of Nonalcoholic Fatty Liver Disease

Hoang, S. A., Oseini, A. M., Feaver, R. E., Cole, B. K., Asgharpour, A., Vincent, R. J., Siddiqui, M. S., Lawson, M. J., Day, N., Taylor, J. M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48746-5 · Cited by 195

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

Raverdy, V., Tavaglione, F., Chatelain, E., Lassailly, G., Vincentis, A. D., Gentilucci, U. V., Qadri, S. U., Caiazzo, R. J., Verkindt, H., Saponaro, C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03283-1 · Cited by 197

The Protective Effects of Live and Pasteurized Akkermansia muciniphila and Its Extracellular Vesicles against HFD/CCl4-Induced Liver Injury

Raftar, S. K. A., Ashrafian, F., Yadegar, A., Lari, A., Moradi, H. R., Shahryari, A., Azimirad, M., Alavifard, H., Mohsenifar, Z., Davari, M., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00484-21 · Cited by 168

The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease

Perakakis, N., Stefanakis, K., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154320 · Cited by 168

Transcriptional network analysis implicates altered hepatic immune function in NASH development and resolution

Haas, J. T., Vonghia, L., Mogilenko, D. A., Verrijken, A., Molendi-Coste, O., Fleury, S., Deprince, A., Nikitin, A., Woitrain, E., Ducrocq-Geoffroy, L., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0076-1 · Cited by 155

Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)

Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158

A human multi-lineage hepatic organoid model for liver fibrosis

Guan, Y., Enejder, A., Wang, M., Fang, Z., Cui, L., Chen, S.-Y., Wang, J., Tan, Y., Wu, M., Chen, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26410-9 · Cited by 149

QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis

You, K., Wang, L., Chou, C., Liu, K., Nakata, T., Jaiswal, A., Yao, J., Lefkovith, A. J., Omar, A. S., Perrigoue, J., et al. (2020) · Science · doi:10.1126/science.abb6896 · Cited by 150

Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

Yu, J., Zhu, C., Wang, X., Kim, K., Bartolome, A., Dongiovanni, P., Yates, K. P., Valenti, L., Carrer, M., Sadowski, T., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe1692 · Cited by 132

Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication

Loft, A., Alfaro, A. J., Schmidt, S. F., Pedersen, F. B., Terkelsen, M. K., Puglia, M., Chow, K. K., Feuchtinger, A., Troullinaki, M., Maida, A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.005 · Cited by 129

Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease

Fujiwara, N., Kubota, N., Crouchet, É., Koneru, B., Marquez, C. A., Jajoriya, A. K., Panda, G., Qian, T., Zhu, S., Goossens, N., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo4474 · Cited by 126

Hepatic sexual dimorphism — implications for non-alcoholic fatty liver disease

Lefèbvre, P., & Staels, B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00538-6 · Cited by 121

CD4+ T cell activation and inflammation in NASH-related fibrosis

Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967410 · Cited by 113

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

Baselli, G., Dongiovanni, P., Rametta, R., Meroni, M., Pelusi, S., Maggioni, M., Badiali, S., Pingitore, P., Maurotti, S., Montalcini, T., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319226 · Cited by 106

Transcriptional Dynamics of Hepatic Sinusoid‐Associated Cells After Liver Injury

Terkelsen, M. K., Bendixen, S. M., Hansen, D., Scott, E. A. H., Moeller, A. F., Nielsen, R., Mandrup, S., Schlosser, A. G., Andersen, T. L., Sørensen, G. L., et al. (2020) · Hepatology · doi:10.1002/hep.31215 · Cited by 107

Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi

Xiong, X., Wang, Q., Wang, S., Zhang, J., Liu, T., Guo, L., Yu, Y., & Lin, J. D. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2018.12.004 · Cited by 100

Transcriptional regulation of Hepatic Stellate Cell activation in NASH

Marcher, A.-B., Bendixen, S. M., Terkelsen, M. K., Hohmann, S. S., Hansen, M. H., Larsen, B. D., Mandrup, S., Dimke, H., Detlefsen, S., & Ravnskjaer, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-39112-6 · Cited by 95

Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD

Pantano, L., Agyapong, G., Shen, Y., Zhuo, Z., Fernández-Albert, F., Rust, W., Knebel, D., Hill, J., Boustany, C., Doerner, J. F., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96966-5 · Cited by 97

Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway

Jiang, B., Wang, D., Hu, Y., Li, W., Liu, F., Zhu, X., Li, X., Zhang, H., Bai, H., Yang, Q., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101462 · Cited by 90

Krüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease

Oishi, Y., & Manabe, I. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00069 · Cited by 76

Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes

Gerhard, G. S., Legendre, C., Still, C. D., Chu, X., Petrick, A. T., & DiStefano, J. K. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00122 · Cited by 70

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Fujiwara, N., Kobayashi, M., Fobar, A. J., Hoshida, A., Marquez, C. A., Koneru, B., Panda, G., Taguri, M., Qian, T., Raman, I., et al. (2021) · Med · doi:10.1016/j.medj.2021.03.017 · Cited by 70

Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)

Vandel, J., Dubois‐Chevalier, J., Gheeraert, C., Derudas, B., Raverdy, V., Thuillier, D., Gaal, L., Francque, S., Pattou, F., Staels, B., et al. (2021) · Hepatology · doi:10.1002/hep.31312 · Cited by 61

Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice

Higuchi, S., Ahmad, T. R., Argueta, D. A., Perez, P. A., Zhao, C., Schwartz, G. J., DiPatrizio, N. V., & Haeusler, R. A. (2020) · Gut · doi:10.1136/gutjnl-2019-319693 · Cited by 65

Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα

Liang, N., Damdimopoulos, A., Goñi, S., Huang, Z.-Q., Vedin, L.-L., Jakobsson, T., Giudici, M., Ahmed, O., Pedrelli, M., Barilla, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09524-z · Cited by 56

Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic Steatohepatitis

Rui, L., & Lin, J. D. (2022) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062220-105200 · Cited by 59

Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction

Du, K., Umbaugh, D. S., Wang, L., Jun, J. H., Dutta, R. K., Oh, S., Ren, N., Zhang, Q., Ko, D. C., Ferreira, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57616-w · Cited by 61

MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists

Cooreman, M. P., Vonghia, L., & Francque, S. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111688 · Cited by 55

Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis

Bobowski, M., Boulet, C., Zummo, F. P., Dubois‐Chevalier, J., Gheeraert, C., Saleh, M. B., Strub, J., Farce, A., Ploton, M., Guille, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33063-9 · Cited by 52

A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells

Kasahara, N., Imi, Y., Amano, R., Shinohara, M., Okada, K., Hosokawa, Y., Imamori, M., Tomimoto, C., Kunisawa, J., Kishino, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-46404-5 · Cited by 50

Dermatopontin, A Novel Adipokine Promoting Adipose Tissue Extracellular Matrix Remodelling and Inflammation in Obesity

Unamuno, X., Gómez‐Ambrosi, J., Ramírez, B., Rodríguez, A., Becerril, S., Valentí, V., Moncada, R., Silva, C., Salvador, J., Frühbeck, G., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041069 · Cited by 50

Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes

Ramnath, D., Irvine, K. M., Lukowski, S. W., Horsfall, L. U., Loh, Z., Clouston, A. D., Patel, P. J., Fagan, K. J., Iyer, A., Lampe, G., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120274 · Cited by 47

hnRNPU/TrkB Defines a Chromatin Accessibility Checkpoint for Liver Injury and Nonalcoholic Steatohepatitis Pathogenesis

Xiong, J., Liu, T., Mi, L., Kuang, H., Xiong, X., Chen, Z., Li, S., & Lin, J. D. (2019) · Hepatology · doi:10.1002/hep.30921 · Cited by 46

Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study

Morrison, M. C., Kleemann, R., van Koppen, A., Hanemaaijer, R., & Verschuren, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00132 · Cited by 44

Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population

Wargny, M., Ducluzeau, P., Petit, J., May, C. L., Smati, S., Arnaud, L., Pichelin, M., Bouillet, B., Lannes, A., Blanchet, O., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.09.008 · Cited by 44

Multi-Omics Insights into Functional Alterations of the Liver in Insulin-Deficient Diabetes Mellitus

Backman, M., Flenkenthaler, F., Blutke, A., Dahlhoff, M., Ländström, E., Renner, S., Philippou‐Massier, J., Krebs, S., Rathkolb, B., Prehn, C. P., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.011 · Cited by 41

Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies

Català-Senent, J. F., Hidalgo, M. R., Berenguer, M., Parthasarathy, G., Malhi, H., Malmierca-Merlo, P., de la Iglesia-Vayá, M., & Garcia‐García, F. (2021) · Biology of Sex Differences · doi:10.1186/s13293-021-00368-1 · Cited by 39

GARP on hepatic stellate cells is essential for the development of liver fibrosis

Zhang, X., Sharma, P., Maschmeyer, P., Hu, Y., Lou, M., Kim, J., Fujii, H., Unutmaz, D., Schwabe, R. F., & Winau, F. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.043 · Cited by 42

Incretin combination therapy for the treatment of non-alcoholic steatohepatitis

Kannt, A., Madsen, A. N., Kammermeier, C., Elvert, R., Klöckener, T., Bossart, M., Haack, T., Evers, A., Lorenz, K., Hennerici, W., et al. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14035 · Cited by 37

PPARα and NCOR/SMRT corepressor network in liver metabolic regulation

Kang, Z., & Fan, R. (2020) · The FASEB Journal · doi:10.1096/fj.202000055rr · Cited by 42

Selenotranscriptome Network in Non-alcoholic Fatty Liver Disease

Day, K., Seale, L. A., Graham, R. M., & Cardoso, B. R. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.744825 · Cited by 38

Tumor-associated neutrophils attenuate the immunosensitivity of hepatocellular carcinoma

Teo, J. M. N., Chen, Z., Chen, W., Tan, R. J. Y., Cao, Q., Chu, Y., Ma, D., Chen, L., Yu, H., Lam, K.-H., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20241442 · Cited by 32

Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies

Bourganou, M. V., Chondrogianni, M. E., Kyrou, I., Flessa, C., Chatzigeorgiou, A., Oikonomou, E. K., Lambadiari, V., Randeva, H. S., & Kassi, E. N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041589 · Cited by 33

Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan

Park, J. G., Mok, J. S., Han, Y. I., Park, T. S., Kang, K. W., Choi, C. S., Park, J., & Park, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-40322-1 · Cited by 30

Multi-Omics Integration Highlights the Role of Ubiquitination in CCl4-Induced Liver Fibrosis

Mercado-Gómez, M., Lopitz‐Otsoa, F., Azkargorta, M., Serrano‐Maciá, M., Lachiondo‐Ortega, S., Goikoetxea‐Usandizaga, N., Agudo, R. R., Fernández‐Ramos, D., Bizkarguenaga, M., Juan, V. G., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239043 · Cited by 29

Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control

Montgomery, M. K., Bayliss, J. A., Nie, S., Nardo, W. D., Keenan, S. N., Miotto, P. M., Karimkhanloo, H., Huang, C., Schittenhelm, R. B., Don, A. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28889-2 · Cited by 33

Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease

Sen, P., Govaere, O., Sinioja, T., McGlinchey, A., Geng, D., Ratziu, V., Bugianesi, E., Schattenberg, J. M., Vidal-Puig, A., Allison, M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104949 · Cited by 28

DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP

Ye, D., Wang, Y., Deng, X., Zhou, X., Liu, D., Zhou, B., Zheng, W., Wang, X., & Fang, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05657-8 · Cited by 28

Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis

Das, S. R., Finney, A. C., Anand, S. K., Rohilla, S., Liu, Y., Pandey, N. O., Ghrayeb, A., Kumar, D., Núñez, K., Liu, Z., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01134-4 · Cited by 28

Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure

Pan, Q., Ai, W., Chen, Y., Kim, D. M., Shen, Z., Yang, W., Jiang, W., Sun, Y., Safe, S. H., & Guo, S. (2023) · Diabetes · doi:10.2337/db23-0180 · Cited by 26

Hepatic adaptation to chronic metabolic stress primes tumorigenesis

Tzouanas, C. N., Shay, J. E. S., Sherman, M. S., Rubin, A. J., Mead, B. E., Dao, T. T., Tao, J., Lehrich, B. M., Eng, G. M., Patterson-Fortin, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.031 · Cited by 32

Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3D MASH model

Kostadinova, R. M., Ströbel, S., Chen, L., Fiaschetti‐Egli, K., Gadient, J., Pawlowska, A., Petitjean, L., Bieri, M., Thoma, E., & Petitjean, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-55438-2 · Cited by 21

A novel immune-related genes signature after bariatric surgery is histologically associated with non-alcoholic fatty liver disease

Song, Y., Zhang, J., Wang, H., Guo, D., Yuan, C., Liu, B., Zhong, H., Li, D., & Li, Y. (2021) · Adipocyte · doi:10.1080/21623945.2021.1970341 · Cited by 22

Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study

Albadawy, R. M., Agwa, S. H. A., Khairy, E., Saad, M., Touchy, N. E., Othman, M. O., & Matboli, M. (2021) · Biomedicines · doi:10.3390/biomedicines9091248 · Cited by 22

High-Protein Mulberry Leaves Improve Glucose and Lipid Metabolism via Activation of the PI3K/Akt/PPARα/CPT-1 Pathway

Shan, Z., Zhang, H., He, C., An, Y., Huang, Y., Fu, W., Wang, M., Du, Y., Xie, J., Yang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168726 · Cited by 21

Emerging Insights into the Role of BDNF on Health and Disease in Periphery

Ichimura‐Shimizu, M., Kurrey, K., Miyata, M., Dezawa, T., Tsuneyama, K., & Kojima, M. (2024) · Biomolecules · doi:10.3390/biom14040444 · Cited by 20

Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content

Mazzini, G. S., Khoraki, J., Browning, M. G., Wu, J., Zhou, H., Price, E. T., Wolfe, L. G., Mangino, M. J., & Campos, G. M. (2021) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-021-04908-3 · Cited by 20

Posttranscriptional regulation of the human LDL receptor by the U2-Spliceosome

Zanoni, P., Panteloglou, G., Othman, A., Haas, J. T., Meier, R., Rimbert, A., Futema, M., Abou Khalil, Y., Norrelykke, S. F., Rzepiela, A. J., et al. (2022) · Circulation Research · doi:10.1161/circresaha.120.318141 · Cited by 27

Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis

Mazzini, G. S., Khoraki, J., Dozmorov, M. G., Browning, M. G., Wijesinghe, D. S., Wolfe, L. G., Gurski, R. R., & Campos, G. M. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3938-z · Cited by 18

Expression of Fibrosis-Related Genes in Liver and Kidney Fibrosis in Comparison to Inflammatory Bowel Diseases

Jerala, M., Hauptman, N., Kojc, N., & Zidar, N. (2022) · Cells · doi:10.3390/cells11030314 · Cited by 18

Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease

Ilieva, M. S., Dao, J., Miller, H. E., Madsen, J. H., Bishop, A. J. R., Kauppinen, S., & Uchida, S. (2022) · Non-Coding RNA · doi:10.3390/ncrna8040056 · Cited by 16

Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease

Dubois, V., Lefèbvre, P., Staels, B., & Eeckhoute, J. (2024) · Gut · doi:10.1136/gutjnl-2023-331741 · Cited by 17

Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder

Yamaji, K., Iwabuchi, S., Tokunaga, Y., Hashimoto, S., Yamane, D., Toyama, S., Kono, R., Kitab, B., Tsukiyama–Kohara, K., Osawa, Y., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115379 · Cited by 15

Hepatic‐specific Pgc‐1α ablation drives fibrosis in a MASH model

Arconzo, M., Piccinin, E., Pasculli, E., Cariello, M., Loiseau, N., Bertrand‐Michel, J., Guillou, H., Matrella, M. L., Villani, G., & Moschetta, A. (2024) · Liver International · doi:10.1111/liv.16052 · Cited by 14

HPS protects the liver against steatosis, cell death, inflammation, and fibrosis in mice with steatohepatitis

Yang, Y., Liu, X., Chen, H., Wang, P., Yao, S., Zhou, B., Yin, R., Li, C., Wu, C., Yang, X., et al. (2022) · FEBS Journal · doi:10.1111/febs.16430 · Cited by 14

Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins

Catalán, V., Domench, P., Gómez‐Ambrosi, J., Ramírez, B., Becerril, S., Mentxaka, A., Rodrı́guez, A., Valentí, V., Moncada, R., Baixauli, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169222 · Cited by 13

Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease

Goossens, N., & Jornayvaz, F. R. (2017) · Nutrients · doi:10.3390/nu9101077 · Cited by 14

Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr- deficient mice

Henry, D., Baugé, E., Hennuyer, N., Ory, K., Derudas, B., Vallez, E., Deprince, A., Lefèbvre, P., Haas, J. T., Staels, B., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adj8192 · Cited by 14

Time-of-day-dependent variation of the human liver transcriptome and metabolome is disrupted in MASLD

Johanns, M., Haas, J. T., Raverdy, V., Vandel, J., Chevalier-Dubois, J., Guille, L., Derudas, B., Legendre, B., Caiazzo, R. J., Verkindt, H., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100948 · Cited by 13

Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery

Fu, C., Zhou, Y. J., Wu, Z., Li, Y., Zhou, W., & Wang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.611213 · Cited by 13

Transcriptomics Reveals Discordant Lipid Metabolism Effects between In Vitro Models Exposed to Elafibranor and Liver Samples of NAFLD Patients after Bariatric Surgery

Boeckmans, J., Gatzios, A., Heymans, A., Rombaut, M., Rogiers, V., Kock, J. D., Vanhaecke, T., & Rodrigues, R. M. (2022) · Cells · doi:10.3390/cells11050893 · Cited by 13

SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH

Cano, L., Desquilles, L., Ghukasyan, G., Angenard, G., Landreau, C., Corlu, A., Clément, B., Turlin, B., Ferrec, E. L., Aninat, C., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100936 · Cited by 12

Identification of the distinctive role of DPT in dilated cardiomyopathy: a study based on bulk and single-cell transcriptomic analysis

Lu, Y., Wu, Q., Liao, J., Zhang, S., Lü, K., Yang, S., Wu, Y., Dong, Q., Yuan, J. T., Zhao, N., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2913 · Cited by 11

Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis

Li, Y., Yuan, S., Yin, J.-Y., Yang, K., Zhou, X.-G., Xie, W., & Wang, Q. (2022) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v14.i7.1265 · Cited by 12

Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives

Chen, Y., Bian, S., & Le, J. (2025) · Genes · doi:10.3390/genes16040399 · Cited by 11

Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD

Fahlbusch, P., Nikolic, A., Hartwig, S., Jacob, S., Kettel, U., Koellmer, C., Al‐Hasani, H., Lehr, S., Müller‐Wieland, D., Knebel, B., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126873 · Cited by 11

A Positive Loop Formed by SOX11 and Periostin Upregulates TGF-β Signals Leading to Skin Fibrosis

Nanri, Y., Nunomura, S., Honda, Y., Takedomi, H., Yamaguchi, Y., & Izuhara, K. (2022) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2022.12.008 · Cited by 10

Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biology

Stiglund, N., Hagström, H., Stal, P. I., Cornillet, M., & Björkström, N. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186097 · Cited by 10

Comprehensive meta-analysis reveals distinct gene expression signatures of MASLD progression

Piras, I. S., & DiStefano, J. K. (2024) · Life Science Alliance · doi:10.26508/lsa.202302517 · Cited by 10

Identification of HTRA1, DPT and MXRA5 as potential biomarkers associated with osteoarthritis progression and immune infiltration

Sun, Y., Yang, H., Guo, J., Du, J., Han, S., & Yang, X. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-07758-7 · Cited by 10

Folic acid depletion as well as oversupplementation helps in the progression of hepatocarcinogenesis in HepG2 cells

Sharma, R., Ali, T., & Kaur, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-21084-9 · Cited by 9

Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift

Migdał, M., Tralle, E., Nahia, K. A., Bugajski, Ł., Kedzierska, K., Garbicz, F., Piwocka, K., Winata, C. L., & Pawlak, M. (2021) · BMC Genomics · doi:10.1186/s12864-021-08173-1 · Cited by 10

Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy

Chen, S., Zeng, Q., Cai, X., Xue, J., Yin, G., Song, P., Tang, L., Klein, C., Tacke, F., Guillot, A., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.98362 · Cited by 8

EMP1 as a Potential Biomarker in Liver Fibrosis: A Bioinformatics Analysis

Chen, X., Lv, X., Han, M., Hu, Y., Zheng, W., Xue, H., Li, Z., Li, K., & Tan, W. (2023) · Gastroenterology Research and Practice · doi:10.1155/2023/2479192 · Cited by 10

Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration

Dijck, E. V., Laere, S. V., Logie, E., Timmermans, S., Fransén, E., Ibrahim, J., Kendall, T. J., Fallowfield, J. A., Mateiu, L. M., Libert, C., et al. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01945-6 · Cited by 7

Identification of key target genes and pathway analysis in nonalcoholic fatty liver disease via integrated bioinformatics analysis

Chen, X., Zhang, L., Wang, Y., Li, R., Yang, M., & Gao, L. (2022) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2022-0006 · Cited by 7

Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease

Ye, H., Sun, M., Su, M., Chen, D., Liu, H., Ma, Y., Luo, W., Li, H., & Xu, F. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1070605 · Cited by 9

Bariatric Surgery Affects Plasma Levels of Alanine Aminotransferase Independent of Weight Loss: A Registry-Based Study

Azulai, S., Grinbaum, R., Beglaibter, N., Eldar, S. M., Rubin, M., Carmi, S., Schyr, R. B., Romano‐Zelekha, O., & Ben‐Zvi, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122724 · Cited by 9

Analysis of machine learning based integration to identify the crosslink between inflammation and immune response in non-alcoholic fatty liver disease through bioinformatic analysis

Yu, R., Huang, Y., Hu, X., & Chen, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32783 · Cited by 5

Tyrosine-sulfated dermatopontin shares multiple binding sites and recognition determinants on triple-helical collagens with proteins implicated in cell adhesion and collagen folding, fibrillogenesis, cross-linking, and degradation

Jensen, M. M., Bonna, A., Frederiksen, S. J., Hamaia, S. W., Højrup, P., Farndale, R. W., & Karring, H. (2022) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2022.140771 · Cited by 5

Identification of hub biomarkers in liver post-metabolic and bariatric surgery using comprehensive machine learning (experimental studies)

Li, Z., Wang, L., Tian, C., Wang, Z., Zhao, H., Yao, Q., Chen, W., Wuyun, Q., Amin, B., Lian, D., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002179 · Cited by 4

Super-enhancer signature reveals key mechanisms associated with resistance to non-alcoholic steatohepatitis in humans with obesityPreprint

Hung, Y.-H., Sritharan, R., Vohl, M., Ilkayeva, O., Biertho, L. D., Tchernof, A., White, P. J., & Sethupathy, P. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.20.457162 · Cited by 4

Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index

Cheikhi, A., Johnson, Z. I., Julian, D. R., Wheeler, S., Feghali‐Bostwick, C. A., Conley, Y. P., Lyons‐Weiler, J., & Yates, C. C. (2020) · PLoS ONE · doi:10.1371/journal.pone.0240986 · Cited by 2

TRAF2 decreases lipid accumulation in hepatocytes under endoplasmic reticulum stress

Li, S., Li, Y., Wang, X., Xia, Z., & Hu, R. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023094 · Cited by 2

The PPARa-regulated dermatopontin is an important contributor to the liver fibrotic response in mouse models and has relevance to fibrosis progression in non-alcoholic fatty liver disease patients

Lefèbvre, P., Francque, S., Lalloyer, F., Baugé, E., Verrijken, A., & Staels, B. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)30606-2

The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice

Pawlak, M., Baugé, E., Bourguet, W., De Bosscher, K., Lalloyer, F., Tailleux, A., Lebherz, C., Lefebvre, P., & Staels, B. (2014) · Hepatology · doi:10.1002/hep.27297 · Cited by 141

Inhibition of thrombospondin-1 and the signal transducer and activator of transcription 3 as independent approaches to attenuate hepatic fibrosis

Min-DeBartolo, J. H. (2019) · OpenBU (Boston University)

Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice

Du, M., Wang, X., Yuan, L., Liu, B., Mao, X., Huang, D., Yang, L., Huang, K., Zhang, F., Wang, Y., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.030 · Cited by 41

The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression

Schulien, I., Hockenjos, B., Schmitt-Graeff, A., Perdekamp, M. G., Follo, M., Thimme, R., & Hasselblatt, P. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0239-8 · Cited by 111